Skip to main content

Clinical Trials › NCT04387734

Active, Not RecruitingPhase 4

Effects of Ocrevus in Relapsing Multiple Sclerosis

Sponsored by Georgia State University

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
60
Target enrollment
1
U.S. states
Feb 2021
Start date
Apr 2026
Expected completion

Interventions / Treatments

OcrelizumabPlatform

Conditions studied

Relapsing Multiple Sclerosis

Where this trial is running (2 sites)

Georgia2 sites
Atlanta · Atlanta

MS centers in Georgia

Compare treatment centers near a trial site by center type, providers and trials.

View Georgia centers

More Phase 4 trials

Browse all Phase 4 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play